CompletedNot Applicable

Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

Denmark25 participantsStarted 2019-08-13

Plain-language summary

Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients under clinical investigation of acromegaly disease with normal kidney function, liver function and hemoglobin levels. Exclusion Criteria: * Medication for acromegaly, adenectomy, liver disease, uncontrolled anemia, severe heart disease, uncontrolled high blood pressure (\>170/100 mmHg), current pregnancy

What they're measuring

Growth hormone levels

Timeframe: 240 min

Trial details

NCT IDNCT03807076

SponsorUniversity of Copenhagen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-14

View on ClinicalTrials.gov More Acromegaly Due to Pituitary Adenoma trials